Provider review, September 2026

TeleClinic Review

TeleClinic names the 503A pharmacy that compounds its medication and shows the standing NAD+ rate beside the introductory one. It sells one tracked compound, and its headline figure is the promotional one.

What TeleClinic charges

TeleClinic is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit TeleClinic

By Nora Castellan, Standards Editor

A named compounder

The pricing footnote says prices reflect compounded medications prepared by licensed 503A pharmacies and names one of them.

That is a checkable fact and it is rarer than it should be. Most sellers here name a regulatory class and stop.

The same pharmacy name appears on another seller reviewed here, which is worth knowing for anyone treating the two as independent quotes.

Introductory and standing, side by side

The NAD+ treatment page prints an introductory first-month figure with the standing rate struck through beside it, and an introductory three-month total with its own comparison figure.

The standing rate is recorded here as the monthly figure, because that is what a subscriber keeps paying. The introductory figure sits in the qualifier.

The three-month introductory total is recorded separately as a prepaid figure rather than divided.

Honest about variation

The site says pricing may vary based on dosage and clinical evaluation, and that a physician must determine eligibility.

It also states plainly that compounded medications are not FDA-approved.

Teleclinic Holdings LLC is named on the homepage, the terms and the privacy policy, which makes the company checkable.

One compound, and the gaps

NAD+ is the only compound tracked here that TeleClinic prices. The rest of its catalogue is GLP-1 medication and vitamin injections.

No list of served states appears.

No certificate of analysis is reachable, and nothing in the live federal warning-letter table attaches to the company or the brand.

Who it's for

  • Readers who want the compounding pharmacy named.
  • Shoppers who want the post-promotional price visible before signing up.
  • Buyers who want a named operating company.
  • Anyone comparing an introductory month against a three-month intro total.

Who should look elsewhere

  • Readers who want more than one peptide from a single seller.
  • Buyers who want the headline figure to be the standing one.
  • Anyone who needs a published state list.
  • Shoppers who want published testing.

Strengths

  • Names Rush Pharmacy as one of the 503A pharmacies that compound its medication
  • Shows the introductory and standing rate together instead of only the discount
  • Names Teleclinic Holdings LLC as the operating company
  • Says pricing may vary by dosage and clinical evaluation rather than implying a fixed rate

Trade-offs

  • Sells only one tracked compound
  • Its headline figure is introductory, and the standing rate is 30 per cent higher
  • Publishes no state list
  • No certificate of analysis is reachable

How we verified this

A provider to compare TeleClinic against

Trellis Vitality

Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.

Read the full Trellis Vitality review

Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit Trellis Vitality

Frequently asked questions

Is the advertised price what I keep paying?

No. The headline is an introductory first-month figure, with the standing rate printed beside it. The standing rate is roughly a third higher.

Which pharmacy compounds the medication?

The pricing footnote names one 503A pharmacy. The same pharmacy is named by another seller reviewed here.

What else does TeleClinic sell?

GLP-1 medication and vitamin injections. NAD+ is the only compound tracked here that it prices.

Will my price be the published one?

The site says pricing may vary based on dosage and clinical evaluation, and that a physician must determine eligibility first.

TeleClinic is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit TeleClinic